Subscribe to Vendors

Vendors

F&P increases guidance, in part due to coronavirus outbreak

 - 
03/05/2020

IRVINE, Calif. – Fisher & Paykel Healthcare has updated its revenue and earnings guidance for the financial year ended March 31, 2020, due to better-than-expected sales in its home care product group.

Inogen expects better second half of 2020

Officials say Q1 will still be impacted by manufacturing challenges
 - 
02/28/2020

GOLETA, Calif. – Following Inogen’s multiple years of high revenue growth, the fourth quarter of 2019 represented a “slowdown,” acknowledges CEO Scott Wilkinson.

Oventus Medical gains traction in DME channel

 - 
02/28/2020

BRISBANE, Australia – Oventus Medical, which makes oral devices to treat obstructive sleep apnea, has snagged a key contract in its quest to leverage the DME channel as part of its go-to-market strategy.

Rowheels ‘redefines’ distribution channel

 - 
02/28/2020

MADISON, Wis. – Rowheels has launched RehabPulse.com, an online marketplace for rehab equipment from the top manufacturers and brands.

Inogen acknowledges ‘challenging year’

 - 
02/26/2020

GOLETA, Calif. – Inogen reported revenue of $78.9 million for the fourth quarter of 2019 compared to $86.5 million for the same period in 2018, an 8.8% decrease.

It reported a net loss of $1.4 million vs. a net income of $10 million.

McKesson app: Patient preferred and cost effective

 - 
02/25/2020

ROCK HILL, S.C. – Patients increasingly want what they want, when they want it, says McKesson’s Dylan Ross, and that’s where the company’s new VerbalCare app can help.

Oventus partners with Aeroflow on oral therapy

 - 
02/25/2020

BRISBANE, Australia – Oventus Medical has announced that its oral devices to treat obstructive sleep apnea will now be sold by Aeroflow Healthcare.

Deeper dive on deal

Brightree’s Mellott says SnapWorx brings ‘incremental capabilities’
 - 
02/21/2020

ATLANTA – Brightree’s acquisition of SnapWorx ups the company’s CPAP resupply game, allowing it to better serve providers of varying sizes, says CEO Matt Mellott.

Invacare re-allocates spending to drive new product sales

 - 
02/14/2020

ELYRIA, Ohio – Now that it has a more robust pipeline in place, Invacare needs to more effectively commercialize its new products, says Matthew Monaghan.

Invacare improves operating loss by $7.8M in 2019

 - 
02/10/2020

ELYRIA, Ohio – Invacare reported net sales decreased 4.8% to $232.9 million in the fourth quarter of 2019. It reported an operating loss of $3.8 million vs. a loss of $1.1 million.

Pages